Abstract
The new triazole derivative SCH 56592 has been tested in a National Committee for Clinical Laboratory Standards-adapted in vitro susceptibility test, and its activity against 12 isolates of Blastomyces dermatitidis yeast-like forms has been compared with those of amphotericin B, itraconazole, and fluconazole. SCH 56592 was the most active of the four compounds, with an MIC at which 90% of the isolates are inhibited of 0.06 microgram/ml and a minimal fungicidal concentration at which 90% of the isolates are inhibited of 4 micrograms/ml. The results of the treatment of mice infected with B. dermatitidis with three different doses of SCH 56592 (25, 5, or 1 mg/kg of body weight), amphotericin B (1 mg/kg), or itraconazole (150 mg/kg) confirmed the potent activity of SCH 56592. Survival was prolonged at each dose of SCH 56592, and sterilization of the lungs occurred in the high-dose group but not in the groups treated with itraconazole or fluconazole. SCH 56592 is a promising new azole antifungal drug that should be studied in humans with blastomycosis.
Full Text
The Full Text of this article is available as a PDF (188.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Harvey R. P., Schmid E. S., Carrington C. C., Stevens D. A. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am Rev Respir Dis. 1978 Apr;117(4):695–703. doi: 10.1164/arrd.1978.117.4.695. [DOI] [PubMed] [Google Scholar]
- Pappas P. G., Bradsher R. W., Chapman S. W., Kauffman C. A., Dine A., Cloud G. A., Dismukes W. E. Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 1995 Feb;20(2):267–271. doi: 10.1093/clinids/20.2.267. [DOI] [PubMed] [Google Scholar]
- Stevens D. A., Brummer E., McEwen J. G., Perlman A. M. Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S304–S306. doi: 10.1093/clinids/12.supplement_3.s304. [DOI] [PubMed] [Google Scholar]
- Sugar A. M., Liu X. Comparison of three methods of antifungal susceptibility testing with the proposed NCCLS standard broth macrodilution assay: lack of effect of phenol red. National Committee for Clinical Laboratory Standards. Diagn Microbiol Infect Dis. 1995 Mar;21(3):129–133. doi: 10.1016/0732-8893(95)00067-k. [DOI] [PubMed] [Google Scholar]
- Sugar A. M., Picard M. Treatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent. Antimicrob Agents Chemother. 1995 Apr;39(4):996–997. doi: 10.1128/aac.39.4.996. [DOI] [PMC free article] [PubMed] [Google Scholar]